Essex Bio-Technology Limited, an investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally. It opera...
Essex Bio-Tech schedules board meeting to review interim results, consider dividend
Essex Bio-Tech expects H1 revenue down about 10%, profit down about 30% on China VAT hike
The Island of Misfit Stocks: From Elon's Giga Press to Real Estate Defaults
Hong Kong's Schizophrenic Market: From Surgical Robots to MSG
HKEX Mid-Year Divergence: CIDI's Revenue Surge and Shifting Capital Allocation
Hong Kong's Strange New Reality: Why Broad Market Narratives Are Dead